ASX 0.76% $62.48 asx limited

re: + + my favourite biotechs + + I have added the dates of...

  1. 22,691 Posts.
    re: + + my favourite biotechs + + I have added the dates of Annual Meetings, if available.

    1. CST: expecting Patent Approvals from the FDA and Japan:
    http://www.hotcopper.com.au/post_thread.asp?fid=1&tid=113028#311493
    AM:?

    2. MBP: Current trial to finish in Sept and results in Nov:
    http://www.hotcopper.com.au/post_thread.asp?fid=1&tid=52191&sym=MBP#130595
    AM: ?

    3. EPT: Interesting stock with Announcement(s) on the Topical formulation to come in coming weeks:
    http://www.hotcopper.com.au/post_thread.asp?fid=1&tid=61463&sym=EPT#156349
    AM: 1 Oct-Needs to deliver the goods.

    4. PGL: Waiting for developments: discussions with PHARMA:
    http://www.hotcopper.com.au/post_thread.asp?fid=1&tid=104816#287956
    AM:? Nov. It will be interesting to know if discussions with a Pharma will be concluded before the AM.

    5. SLT: Since its agreement with the Burnet Institute on 23 Jan. 2003, has achieved much over that short period:
    http://www.hotcopper.com.au/post_thread.asp?fid=1&tid=124179#348504
    Has just delivered its half year report.

    I accord the following urgency ratings: items 1, 5, 2, 3-4. (That rating assists me with deciding what additional money to invest in what selections).

    Gerry
    Holds shares in items 1-5 incl.
    Readers, please do your own research and you decide if and when to buy, hold or sell any stocks.

    Further info about individual stocks can be obtained by clicking on the "Search" button: Top left.

 
watchlist Created with Sketch. Add ASX (ASX) to my watchlist
(20min delay)
Last
$62.48
Change
0.470(0.76%)
Mkt cap ! $12.11B
Open High Low Value Volume
$62.30 $62.59 $61.80 $27.12M 434.9K

Buyers (Bids)

No. Vol. Price($)
1 830 $62.47
 

Sellers (Offers)

Price($) Vol. No.
$62.52 7 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
ASX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.